Ipratropium: Difference between revisions
Ajgausepohl (talk | contribs) (edits) |
Ajgausepohl (talk | contribs) (edits) |
||
| Line 28: | Line 28: | ||
===Common=== | ===Common=== | ||
*Urinary retention | |||
*Increased intraocular pressure | |||
*Bitter taste in mouth | |||
*Dry throat/Cough | |||
*Nasal dryness | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 01:04, 2 June 2015
General
- Type: Anticholinergic Agent
- Dosage Forms: Oral inhalation
- Common Trade Names: Atrovent
Adult Dosing
Asthma: 0.5mg Nebulized q20min, up to 3 doses
COPD: 0.5mg Nebulized q20mins, up to 3 doses
Pediatric Dosing
- Children ≤5 years: 0.25 mg Neb q20mins, up to 3 doses
- Children ≤12 years: 0.25-0.5 mg Neb q20mins, up to 3 doses
- Children >12 years: Refer to adult dosing
Special Populations
- Pregnancy Rating: B
- Lactation risk categories: L3
- Renal Dosing - none
- Hepatic Dosing - none
Contraindications
- Allergy to anticholenergics (Atropine, Ipatropium)
- Not to be used as sole rescue agent in acute exacerbation
Adverse Reactions
Serious
Common
- Urinary retention
- Increased intraocular pressure
- Bitter taste in mouth
- Dry throat/Cough
- Nasal dryness
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: